** Shares of telehealth firm Doximity DOCS.N rise 24.4% to $72.50 premarket
** On Thursday, co forecast fiscal 2025 rev. to be between $564.6 mln and $565.6 mln, up from its previous range of $535 mln to $540 mln; analysts estimate 2025 rev. to be $554.3 mln - LSEG-compiled data
** Co forecasts Q4 rev. to be between $132.5 mln and $133.5 mln, above analysts' est of $129.2 mln
** Co reported Q3 adj. profit of 45 cents/shr vs analysts' est. of 34 cents/shr
** Co posted Q3 revenue of $168.6 mln vs estimates of $152.8 mln
** At least six brokerages raised PT on DOCS post results
** DOCS gained ~87% in 2024
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。